
Anthem Biosciences ranks 19th by market capitalisation among 105 Healthcare companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 86.4 compares with a peer median of 42.8.
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,773.60 | -1.69% | 4,25,546 | 35.2 | 5.09 | 14.7% | +12.5% |
| Divi's Laboratories | 9,586.00 | +0.38% | 2,54,478 | 87.0 | 15.18 | 16.2% | +12.5% |
| Torrent Pharmaceuticals | 4,693.90 | -1.64% | 1,58,863 | 72.8 | 18.94 | 27.1% | +12.5% |
| Zydus Lifesciences | 1,151.30 | -0.71% | 1,15,848 | 25.7 | 4.27 | 19.7% | +12.5% |
| Apollo Hospitals Enterprise | 7,884.00 | -0.39% | 1,13,360 | 54.3 | 11.96 | 22.0% | +12.5% |
| Laurus Labs | 2,052.90 | +0.14% | 1,10,827 | 101.4 | 20.91 | 18.2% | +12.5% |
| Cipla | 1,333.00 | -0.54% | 1,07,677 | 32.0 | 3.13 | 11.8% | +12.5% |
| Mankind Pharma | 2,496.00 | -0.16% | 1,03,042 | 50.4 | 6.32 | 12.5% | +12.5% |
| Dr. Reddy's Laboratories | 1,194.90 | -1.08% | 99,533 | 30.1 | 2.60 | 12.1% | +12.5% |
| Aurobindo Pharma | 1,677.90 | -0.88% | 97,453 | 26.3 | 2.57 | 9.9% | +12.5% |
| Anthem Biosciences | 885.95 | -0.49% | 49,765 | 86.4 | 16.36 | 21.7% | +22.0% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Anthem Biosciences' listed peers in Healthcare include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Apollo Hospitals Enterprise and Laurus Labs, ranked here by market capitalisation.
Anthem Biosciences trades at a P/E of 86.4, against a median of 42.8 across the 10 Healthcare peers shown.
By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹49,765 crore for Anthem Biosciences.
Track ANTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.